Form 4 holding
CFO and Chief Business Officer
Athira Pharma, Inc.
- Security class
- Common Stock
- Shares / value
- 97,532
- Estimated value
- $55,203
- Report date
- 05 Sep 2024
- Price
- $0.5660
- Ownership
- Direct
Andrew Gengos - CFO and Chief Business Officer at LeonaBio, Inc.
Issuer-level insider activity
- Role
- CFO and Chief Business Officer
- Issuer ticker
- LONA on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Andrew Gengos since 19 Aug 2025
Reported holdings for Andrew Gengos in LeonaBio, Inc.
Form 4 holding
CFO and Chief Business Officer
Athira Pharma, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 280,000
- Estimated value
- Report date
- 14 Feb 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Andrew Gengos in LeonaBio, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.